Tempus AI Shares Outstanding 2023-2024 | TEM

Tempus AI shares outstanding history from 2023 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Tempus AI shares outstanding for the quarter ending September 30, 2024 were 0.166B, a 161.69% increase year-over-year.
  • Tempus AI 2023 shares outstanding were 0.063B, a 0.43% decline from 2022.
  • Tempus AI 2022 shares outstanding were 0.063B, a INF% increase from .
  • Tempus AI shares outstanding were 0B, a NAN% decline from .
Tempus AI Annual Shares Outstanding
(Millions of Shares)
2023 63
2022 63
Tempus AI Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 166
2024-06-30 82
2024-03-31 63
2023-12-31
2023-09-30 63
2023-06-30 63
2023-03-31 63
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.232B $0.321B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.872B 57.28
Hims & Hers Health (HIMS) United States $8.842B 224.83
Inspire Medical Systems (INSP) United States $5.430B 169.35
IRhythm Technologies (IRTC) United States $3.397B 0.00
Privia Health (PRVA) United States $2.723B 226.90
Enovis (ENOV) United States $2.544B 16.95
Azenta (AZTA) United States $2.469B 114.98
Clover Health Investments (CLOV) United States $2.225B 0.00
Schrodinger (SDGR) United States $1.886B 0.00
Omnicell (OMCL) United States $1.826B 39.83
10x Genomics (TXG) United States $1.773B 0.00
Phreesia (PHR) United States $1.680B 0.00
Butterfly Network (BFLY) United States $0.937B 0.00
Talkspace (TALK) United States $0.608B 0.00
Standard BioTools (LAB) United States $0.529B 0.00
Fulgent Genetics (FLGT) United States $0.507B 0.00
TruBridge (TBRG) United States $0.380B 110.57
Nyxoah SA (NYXH) Belgium $0.369B 0.00
Health Catalyst (HCAT) United States $0.334B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
American Well (AMWL) United States $0.176B 0.00
EUDA Health Holdings (EUDA) Singapore $0.104B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
P3 Health Partners (PIII) United States $0.073B 0.00
CareCloud (CCLD) United States $0.066B 0.00
HeartBeam (BEAT) United States $0.065B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
Outset Medical (OM) United States $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.043B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
MSP Recovery (MSPR) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00